1. 9 Routine use of glycoprotein IIB/IIIA inhibitors is associated with improved survival in primary PCI. (27th November 2017) Authors: Orzalkiewicz, M; Hodson, J; Ludman, P; George, S; Doshi, SN; Khan, S; Mamas, M; Hildick-Smith, D; Townend, JN; Calvert, PA Journal: Heart Issue: Volume 103(2017)Supplement 7 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗